| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/13/2000 | WO1999053060A3 Glaucoma therapeutics and diagnostics based on a novel human transcription factor |
| 01/13/2000 | WO1999046367A8 Methods of diagnosis and triage using cell activation measures |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2335920A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970621A1 Bilberry-containing drinks and process for producing the same |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
| 01/12/2000 | EP0969846A1 Compositions and methods for reducing ocular hypertension |
| 01/12/2000 | EP0969836A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/12/2000 | EP0969814A1 Opthalmic non-irritating iodine medicament and method |
| 01/12/2000 | EP0969812A1 Ophthalmic compositions including glycerin and propylene glycol |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/12/2000 | CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid |
| 01/11/2000 | US6013663 Dithiolan derivatives, their preparation and their therapeutic effect |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/06/2000 | WO2000000208A1 Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions |
| 01/06/2000 | WO2000000197A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/06/2000 | WO1998034942A3 Dinucleotides and their use |
| 01/06/2000 | CA2327888A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968183A2 13-thia prostaglandins for use in glaucoma therapy |
| 01/05/2000 | EP0968182A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | CN1240424A Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 01/05/2000 | CN1240361A Use of low molecular weight amino alcohols in ophthalmic compositions |
| 01/04/2000 | US6011045 Inhibitors of bone resorption; anticancer agents |
| 01/04/2000 | US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/04/2000 | US6010699 Administering plasminogen activator |
| 01/04/2000 | CA2161774C Synthetic viscoelastic material for ophthalmic applications |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067236A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999066944A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/29/1999 | EP0966970A1 Antigen specific to meniere's disease and medical use thereof |
| 12/29/1999 | EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 12/29/1999 | EP0966281A1 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 12/29/1999 | CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs. |
| 12/29/1999 | CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion |
| 12/29/1999 | CA2335545A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 12/29/1999 | CA2330175A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | CA2319650A1 Methods for identifying novel multimeric agents that modulate receptors |
| 12/28/1999 | US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer |
| 12/28/1999 | US6008211 Photoactivatable compounds comprising benzochlorin and furocoumarin |
| 12/23/1999 | WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | WO1999066038A1 Angiostatin-binding protein |
| 12/23/1999 | WO1999065942A1 Cyclic somatostatin analogs |
| 12/23/1999 | WO1999065940A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | WO1999065898A1 Imidazolyl derivatives |
| 12/23/1999 | WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 12/23/1999 | WO1999065877A1 Therapeutic biaryl derivatives |
| 12/23/1999 | WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 12/23/1999 | WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 12/23/1999 | WO1999039722A3 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification |
| 12/23/1999 | CA2335435A1 Imidazolyl derivatives |
| 12/23/1999 | CA2335184A1 Cyclic somatostatin analogs |
| 12/23/1999 | CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 12/23/1999 | CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 12/23/1999 | CA2331332A1 Anti-angiogenic proteins and methods of use thereof |
| 12/23/1999 | CA2330228A1 Angiostatin-binding protein |
| 12/22/1999 | EP0965334A1 Liquid respiratory product for intubation |
| 12/22/1999 | EP0965329A1 Skin treatment agents and use thereof for preparing dermatological compositions |
| 12/22/1999 | EP0964678A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions |
| 12/22/1999 | CN1239427A Use of mupirocin for manufacture of medicament for treatment of bacterial infections associated with colonisation of nasopharynx by pathogenic organisms |
| 12/21/1999 | US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists |
| 12/21/1999 | US6004987 Use of ligands which are specific for RXR receptors |
| 12/21/1999 | US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines |
| 12/21/1999 | US6004958 Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention |
| 12/21/1999 | US6004556 Staphylococcus aureus RSBU-1 |
| 12/21/1999 | CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 12/21/1999 | CA2003422C Quinuclidines, their use as medicaments and processes for their preparation |
| 12/16/1999 | WO1999064423A1 Furopyridine derivatives and their therapeutical use |
| 12/16/1999 | WO1999064420A1 β-CARBOLINE COMPOUNDS |
| 12/16/1999 | WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 12/16/1999 | WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 12/16/1999 | WO1999064400A1 INHIBITORS OF p38 |
| 12/16/1999 | WO1999064067A2 Vaccine |
| 12/16/1999 | WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 12/16/1999 | WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064052A1 Novel leukotriene receptor antagonists and their uses |
| 12/16/1999 | WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
| 12/16/1999 | WO1999064041A1 Multibinding agents that modulate nmda receptors |
| 12/16/1999 | WO1999064039A1 Bradykinin antagonists |
| 12/16/1999 | WO1999064038A1 Novel analgesic agents |
| 12/16/1999 | WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 12/16/1999 | WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 12/16/1999 | WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors |
| 12/16/1999 | WO1999063999A1 H1-histamine receptor antagonists |
| 12/16/1999 | WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 12/16/1999 | WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors |
| 12/16/1999 | WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |